Z Li, M Maglione, W Tu, W Mojica, D … - Annals of internal medicine, 2005 - Am Coll Physicians Background: In response to the increase in obesity, pharmacologic treatments for
weight loss have become more numerous and more commonly used. ... Purpose: To
assess the efficacy and safety of weight loss medications approved by the ... Cited by 324 - Related articles - BL Direct - All 8 versions
- ►hhs.gov [PDF] KM McTigue, R Harris, B Hemphill, L Lux, S … - Annals of Internal Medicine, 2003 - Am Coll Physicians Background: Obesity poses a considerable and growing health burden. This review
examines evidence for screening and treating obesity in adults. ... Data
Sources: MEDLINE and Cochrane Library (January 1994 through February 2003). Cited by 320 - Related articles - BL Direct - All 12 versions
R Padwal, SK Li, DCW Lau - International journal of obesity, 2003 - nature.com CONTEXT: Safe and effective strategies to curb rising obesity prevalence rates
are urgently needed and medications may play a more prominent role in future
therapeutic regimens. ... OBJECTIVE: To review systematically the ... Cited by 314 - Related articles - BL Direct - All 10 versions
- ►ahajournals.org S Klein, LE Burke, GA Bray, S Blair, DB … - Circulation, 2004 - Am Heart Assoc Obesity adversely affects cardiac function, increases the risk factors for
coronary heart disease, and is an independent risk factor for cardiovascular
disease. The risk of developing coronary heart disease is directly related ... Cited by 276 - Related articles - BL Direct - All 8 versions
- ►ahajournals.org PWF Wilson, SM Grundy - Circulation, 2003 - Am Heart Assoc Background It is appropriate to consider jointly the effects of low HDL
cholesterol (HDL-C) and high triglyceride levels as components of the metabolic
syndrome (MetS). In observational studies, each of these factors is related ... Cited by 142 - Related articles - BL Direct - All 9 versions
JD Douketis, C Macie, L Thabane, DF … - International Journal of Obesity, 2005 - nature.com Dietary/lifestyle therapy provides <5 kg weight loss after 2–4 y,
pharmacologic therapy provides 5–10 kg weight loss after 1–2 y, and surgical
therapy provides 25–75 kg weight loss after 2–4 y. Weight loss of 5% ... Cited by 106 - Related articles - BL Direct - All 5 versions
GA Bray - Psychiatric Clinics of North America, 2005 - Elsevier A report from the Heart, Lung and Blood Institute of the National Institutes of
Health (NIH) entitled Clinical Guidelines on the Identification, Evaluation, and
Treatment of Overweight and Obesity in Adults—The Evidence Report [1] ... Cited by 103 - Related articles - BL Direct - All 14 versions
SL Norris, X Zhang, A Avenell, E Gregg, CH … - Archives of internal medicine, 2004 - Am Med Assoc Results Sufficient data for the meta-analysis were available for fluoxetine,
orlistat, and sibutramine. Fourteen randomized, placebo-controlled trials were
included in the review, with a total of 2231 patients. Pharmacotherapy ... Cited by 90 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org DE Kelley, LH Kuller, TM McKolanis, P Harper … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—Weight loss resulted in substantial improvement (P < 0.001) in HbA 1c
(−1.6 ± 0.3 vs. −1.0 ± 0.4%; NS between groups). IS improved significantly
more with orlistat (Δ2.2 ± 0.4 vs. Δ1.2 ± 0.4 mg · min −1 · kg −1 ... Cited by 86 - Related articles - BL Direct - All 12 versions
A Avenell, TJ Brown, MA McGee, MK … - Journal of Human Nutrition and Dietetics, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 67 - Related articles - BL Direct - All 7 versions
